喘与较低的身体活动水平之间的关联:西班牙一项基于人口的病例控制研究的结果
Javier De-Miguel-Diez1, Carlos Llamas-Saez2, Teresa Saez Vaquero3
1Respiratory Care Department, Gregorio Marañón General University Hospital, 28007 Madrid, Spain.
Journal of clinical medicine
|January 26, 2024
概括
2014-2020年期间,患有喘的西班牙成年人体育活动 (PA) 患病率保持稳定. 然而,步行频率有所改善,尽管喘与整体PA的减少有关.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 身体活动 (PA) 对于控制喘至关重要.
- 了解患有喘的成年人中的PA趋势对于公共卫生倡议至关重要.
- 之前的研究还没有完全阐明2014年至2020年间患有喘的西班牙成年人的PA变化.
研究的目的:
- 为了确定从2014年到2020年在西班牙成年人中患喘的PA患病率的变化.
- 为了研究性别差异和其他影响PA坚持这一群体的因素.
- 为了比较患有喘和没有喘的人之间的PA水平.
主要方法:
- 一个横截面的,基于人群的,匹配的病例控制研究.
- 利用了2014年和2020年欧洲卫生访谈调查对西班牙 (EHISS) 的数据.
- 分析了患有喘和没有喘的成年人中的PA患病率,步行频率和相关变量.
主要成果:
- 肺炎的患病率保持稳定 (57.2%与55.7%相比).
- 步行频率 (≥2天/周) 显著增加 (73.9%至82.2%,p < 0.001).
- 喘与较低的血压 (OR 0.87) 和较少的行走日 (OR 0.84) 相关.
结论:
- 2014年至2020年间,在患有喘的西班牙成年人中,步行频率有所改善.
- 年龄较小,男性性别,自我健康状况较好,BMI较低等因素与更高的血压相关.
- 喘仍然是与减少体力活动和步行频率相关的一个因素.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma: Pathogenesis and Management
403
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
403
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
207
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
207


